본문 바로가기
KERD
논문KCI 등재

Electrophysiologic Characteristics of Nitrous-Oxide-Associated Peripheral Neuropathy: A Retrospective Study of 76 Patients

Xiuying Fang|Miao Yu|Dongming Zheng|Han Gao|Weishuai Li|Ying Ma
대한신경과학회 (Korean Neurological Association)|2023.01|Journal of Clinical Neurology|제19권 제1호|pp. 44-51

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

severityperipheral neuropathynitrous oxide abuseelectrophysiologic studyvitamin B12

초록

Background and Purpose The electrophysiologic characteristics of peripheral neuropathy secondary to nitrous oxide (N2O) abuse remain unclear. The paper therefore aimed to summarize the electrophysiologic characteristics of N2O-associated peripheral neuropathy and identify the risk factors of severe nerve injury. Methods The electrophysiologic results and clinical data of patients with peripheral neuropathy secondary to N2O abuse at our hospital between 2018 and 2020 were analyzed retrospectively, and their electrophysiologic changes were summarized. Results Most patients exhibited decreased sensory and motor nerve conduction velocities (75% and 76%), decreased sensory nerve and compound motor action potentials (57% and 59%), and prolonged distal motor latency (59%), while a response was absent in 36%. These findings indicate that N2O abuse can result in generalized injury to sensory and motor nerves. Electrophysiologic results indicated axonal neuropathy in 37 cases (49%), demyelinating peripheral neuropathy in 4 (5%), and mixed neuropathy in 12 (16%). Peripheral nerve injury was more common in the lower limbs (72%) than in the upper limbs (42%, p<0.0001). The upper and lower limbs were primarily affected by sensory nerve demyelination (35%) and motor axonal injury (67%), respectively. Subgroup analysis indicated that longer N2O exposure and longer disease course were associated with more-severe motor axonal injury in the lower limbs. Conclusions N2O-associated peripheral neuropathy can lead to sensory and motor nerve injury, with axonal injury being the most common. Injuries were more severe in the lower limbs. Prolonged N2O exposure and disease course increased the severity of motor axonal injury in the lower limbs.

Abstract

Background and Purpose The electrophysiologic characteristics of peripheral neuropathy secondary to nitrous oxide (N2O) abuse remain unclear. The paper therefore aimed to summarize the electrophysiologic characteristics of N2O-associated peripheral neuropathy and identify the risk factors of severe nerve injury. Methods The electrophysiologic results and clinical data of patients with peripheral neuropathy secondary to N2O abuse at our hospital between 2018 and 2020 were analyzed retrospectively, and their electrophysiologic changes were summarized. Results Most patients exhibited decreased sensory and motor nerve conduction velocities (75% and 76%), decreased sensory nerve and compound motor action potentials (57% and 59%), and prolonged distal motor latency (59%), while a response was absent in 36%. These findings indicate that N2O abuse can result in generalized injury to sensory and motor nerves. Electrophysiologic results indicated axonal neuropathy in 37 cases (49%), demyelinating peripheral neuropathy in 4 (5%), and mixed neuropathy in 12 (16%). Peripheral nerve injury was more common in the lower limbs (72%) than in the upper limbs (42%, p<0.0001). The upper and lower limbs were primarily affected by sensory nerve demyelination (35%) and motor axonal injury (67%), respectively. Subgroup analysis indicated that longer N2O exposure and longer disease course were associated with more-severe motor axonal injury in the lower limbs. Conclusions N2O-associated peripheral neuropathy can lead to sensory and motor nerve injury, with axonal injury being the most common. Injuries were more severe in the lower limbs. Prolonged N2O exposure and disease course increased the severity of motor axonal injury in the lower limbs.

참고문헌 (47)

  1. Weimann J, "Toxicity of nitrous oxide", Best Pract Res Clin Anaesthesiol, 17, pp.47~61 (2003)
  2. Becker DE, "Nitrous oxide and the inhalation anesthetics", Anesth Prog, 55, pp.124~130 (2008)
  3. Zheng D, "The sharp rise of neurological disorders associated with recreational nitrous oxide use in China : a single-center experience and a brief review of Chinese literature", J Neurol, 267, pp.422~429 (2020)
  4. van Amsterdam J, "Recreational nitrous oxide use : prevalence and risks", Regul Toxicol Pharmacol, 73, pp.790~796 (2015)
  5. Garakani A, "Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse : a systematic review of the case literature", Am J Addict, 25, pp.358~369 (2016)
  6. Hathout L, "Nitrous oxide-induced B₁₂ deficiency myelopathy : perspectives on the clinical biochemistry of vitamin B12", J Neurol Sci, 301, pp.1~8 (2011)
  7. Nunn JF, "Clinical aspects of the interaction between nitrous oxide and vitamin B12", Br J Anaesth, 59, pp.3~13 (1987)
  8. Buizert A, "When the laughing stops : subacute combined spinal cord degeneration caused by laughing gas use", J Addict Med, 11, pp.235~236 (2017)
  9. Hew A, "Nitrous oxide abuse presenting with acute psychosis and peripheral neuropathy", Aust N Z J Psychiatry, 52, pp.388~ (2018)
  10. Layzer RB, "Neuropathy following abuse of nitrous oxide", Neurology, 28, pp.504~506 (1978)
  11. Hsu CK, "Myelopathy and polyneuropathy caused by nitrous oxide toxicity : a case report", Am J Emerg Med, 30, pp.1016~ (2012)
  12. Morris N, "Severe motor neuropathy or neuronopathy due to nitrous oxide toxicity after correction of vitamin B12deficiency", Muscle Nerve, 51, pp.614~616 (2015)
  13. Fang X, "Skin hyperpigmentation:a rare presenting symptom of nitrous oxide abuse", Clin Toxicol(Phila), 58, pp.476~481 (2020)
  14. Li HT, "Clinical and electrodiagnostic characteristics of nitrous oxide-induced neuropathy in Taiwan", Clin Neurophysiol, 127, pp.3288~3293 (2016)
  15. Van Asseldonk JT, "Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C : diagnostic yield in chronic inflammatory demyelinating polyneuropathy", Brain, 128(Pt 4), pp.880~891 (2005)
  16. Albers JW, "Acquired inflammatory demyelinating polyneuropathies : clinical and electrodiagnostic features", Muscle Nerve, 12, pp.435~451 (1989)
  17. Cheng HM, "Subacute combined degeneration of the spinal cord following recreational nitrous oxide use", BMJ Case Rep, 2013, pp.bcr2012008509~ (2013)
  18. Enticknap JB, "A case of fatal accidental N2O poisoning", Med Sci Law, 1, pp.404~409 (1961)
  19. Garland EL, "Nitrous oxide inhalation among adolescents : prevalence, correlates, and co-occurrence with volatile solvent inhalation", J Psychoactive Drugs, 41, pp.337~347 (2009)
  20. "Drug misuse: findings from the 2016/17 crime survey for England and Wales" (2017)[URL]
  21. Randhawa G, "The increasing recreational use of nitrous oxide : history revisited", Br J Anaesth, 116, pp.321~324 (2016)
  22. Antezana A, "Toxic myelopathy secondary to recreational nitrous oxide abuse", J Neurol Sci, 357, pp.e216~ (2015)
  23. Blanco G, "Myeloneuropathy and macrocytosis associated with nitrous oxide abuse", Arch Neurol, 40, pp.416~418 (1983)
  24. Greenblum DN, "Sequelae of nitrous oxide abuse", Psychosomatics, 23, pp.307~311 (1982)
  25. Gutmann L, "Nitrous oxide-induced myelopathy-neuropathy : potential for chronic misuse by dentists", J Am Dent Assoc, 98, pp.58~59 (1979)
  26. Oussalah A, "Global burden related to nitrous oxide exposure in medical and recreational settings : a systematic review and individual patient data meta-analysis", J Clin Med, 8, pp.551~ (2019)
  27. Pema PJ, "Myelopathy caused by nitrous oxide toxicity", AJNR Am J Neuroradiol, 19, pp.894~896 (1998)
  28. Tani J, "Elucidating unique axonal dysfunction between nitrous oxide abuse and vitamin B12 deficiency", Front Neurol, 10, pp.704~ (2019)
  29. Sahenk Z, "Polyneuropathy from inhalation of N2O cartridges through a whipped-cream dispenser", Neurology, 28, pp.485~487 (1978)
  30. Duque MA, "Nitrous oxide abuse and vitamin B12 action in a 20-year-old woman : a case report", Lab Med, 46, pp.312~315 (2015)
  31. Keddie S, "No laughing matter : subacute degeneration of the spinal cord due to nitrous oxide inhalation", J Neurol, 265, pp.1089~1095 (2018)
  32. Maze M, "Recent advances in understanding the actions and toxicity of nitrous oxide", Anaesthesia, 55, pp.311~314 (2000)
  33. Maler JM, "Homocysteine induces cell death of rat astrocytes in vitro", Neurosci Lett, 347, pp.85~88 (2003)
  34. Pugliese RS, "Subacute combined degeneration of the spinal cord in a patient abusing nitrous oxide and self-medicating with cyanocobalamin", Am J Health Syst Pharm, 72, pp.952~957 (2015)
  35. Chiang TT, "Recreational nitrous oxide abuse-induced vitamin B12 deficiency in a patient presenting with hyperpigmentation of the skin", Case Rep Dermatol, 5, pp.186~191 (2013)
  36. Fatima K, "Motor nerve conduction studies in patients with chronic renal failure", Journal of Rawalpindi Medical College, 14, pp.11~14 (2010)
  37. Jasti DB, "A clinical and electrophysiological study of peripheral neuropathies in predialysis chronic kidney disease patients and relation of severity of peripheral neuropathy with degree of renal failure", J Neurosci Rural Pract, 8, pp.516~524 (2017)
  38. Julian T, "Alcohol-related peripheral neuropathy : a systematic review and meta-analysis", J Neurol, 266, pp.2907~2919 (2019)
  39. Pal PK, "Clinical and electrophysiological studies in vincristine induced neuropathy", Electromyogr Clin Neurophysiol, 39, pp.323~330 (1999)
  40. Sandler SG, "Vincristine-induced neuropathy. A clinical study of fifty leukemic patients", Neurology, 19, pp.367~374 (1969)
  41. Zajączkowska R, "Mechanisms of chemotherapy-induced peripheral neuropathy", Int J Mol Sci, 20, pp.1451~ (2019)
  42. Sultan LI, "Evaluation of the clinical and neurophysiologic parameters of peripheral nerve functions in uremic Egyptian patients", Egypt J Neurol Psychiatr Neurosurg, 44, pp.473~487 (2007)
  43. Taylor SW, "Clinical, physiological and pathological characterisation of the sensory predominant peripheral neuropathy in copper deficiency", J Neurol Neurosurg Psychiatry, 88, pp.839~845 (2017)
  44. Koike H, "Clinicopathologic features of folate-deficiency neuropathy", Neurology, 84, pp.1026~1033 (2015)
  45. Park SB, "Long-term neuropathy after oxaliplatin treatment : challenging the dictum of reversibility", Oncologist, 16, pp.708~716 (2011)
  46. Osmani K, "Taxaneinduced peripheral neuropathy has good long-term prognosis : a 1-to 13-year evaluation", J Neurol, 259, pp.1936~1943 (2012)
  47. Alt RS, "Severe myeloneuropathy from acute high-dose nitrous oxide(N2O)abuse", J Emerg Med, 41, pp.378~380 (2011)

이 간행물의 다른 논문 (13건)

Cerebro-/Cardiovascular Collateral Damage During the COVID-19 Pandemic: Fact or Fiction?Michail I Papafaklis, Lampros K Michalis, Theodoros Karapanayiotides, Georgios Tsivgoulis, Sotirios Giannopoulos, Christos S. Katsouraspp. 1-11Update on the Epidemiology, Pathogenesis, and Biomarkers of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and LeukoencephalopathyYi-Chu Liao, Yumi Yamamoto, 최재철, Masafumi Ihara, Yi-Chung Leepp. 12-27Relationship Between MicroRNA Signature and Arterial Stiffness in Patients With Ischemic Stroke김정민, 박광열, 이상진, 이은선, 김혜련pp. 28-35Can Artificial Intelligence Diagnose Transient Global Amnesia Using Electroencephalography Data?이동아, 박강민, Young Deok Seopp. 36-43Telbivudine-Induced Myopathy: Clinical Features, Histopathological Characteristics, and Risk FactorsChien-Hung Chen, Yung-Yee Chang, King-Wah Chiu, Tsu-Kung Lin, Shun-Sheng Chen, Min-Yu Lan, Hui-Chen Lin, Tsung-Hui Hu, Shu-Fang Chenpp. 52-59
원문 보기